University of Southern California
USC Norris Comprehensive Cancer Center
If you are a patient, please contact Keck Medical Center of USC at 800-USC-CARE.

Trial 0S-17-3


Phase 2a Dose-Rising, Safety, Tolerability and Efficacy Study of Topical SOR007 for Cutaneous Metastases

Type: Treatment
Phase: Phase II
Status: Open to Accrual
Treatments: Chemotherapy: Local
Randomized: No
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Julie Lang, M.D.
Other Trial Staff:  Lusine Raddatz, D.M., Fahim Raian, D.M., Grace Facio, Coordinator, Charlean Ketchens, Coordinator, Marissa Aldana, D.M., America Casillas-Lopez, Coordinator, Rabia Rehman, Coordinator, Apoorva Vishwanath, D.M., Janelle Luevano, Coordinator, Ramy Farag, Coordinator, Brigitte Torres, Coordinator

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.